A Vanderbilt study of a treatment to delay the development of Type 1 diabetes in individuals at high risk did not meet the study goals of delaying progression from normal glucose tolerance to abnormal glucose tolerance or clinical diagnosis, although the study drug, abatacept, impacted immune response and preserved insulin production during the one-year treatment period.

Vanderbilt University Medical Center is part of a select group of health systems nationwide brought together to accelerate the implementation of medical research results that will improve patient outcomes.

A chemical biology research lab fit for an academic medical center is being installed at Wynne High School (WHS) in Wynne, Arkansas, as part of a pilot project of Aspirnaut STEM pipeline at Vanderbilt University Medical Center.

Vanderbilt University Medical Center to be an early adopter as a hospital system integrating the Tennessee Advanced Communications Network into its existing network of emergency providers for redundancy communications in the event of a disaster.

Vanderbilt research found that a new drug company founded by entrepreneur Mark Cuban could save patients $1.29 billion a year based on 2020 Medicare Part D expenditures on just the nine most popular urological drugs.

A study co-led by Vanderbilt researchers found heart failure risk is 19% higher for adults living in rural areas of the U.S., as compared to urban areas, and 34% higher for Black men living in rural areas.